All Curated Mutation Sites in HBV

The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HBV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.

Browse Data by Virus Gene/Protein/Region, Disease OR Description

*Please select one option you are interested in, the page will be automatically redirected.

Virus Gene/Protein

Disease

Description

For highly variable viruses (e.g., HBV, HIV, SARS-CoV-2), ViMIC defaults to displaying mutations in a specific region. Click the green button to search for other regions, or click "Show All" to view all mutations (loading speed may be affected by network conditions).

Show All

BCP

Core Promoter

Core Upstream Regulatory Sequence

Keyword: Occult HBV Infection-22617152

ID	PMID	Mutation	Gene/Protein/Region	Encoding Gene/Protein	Disease	Description	Detail
1	22617152	Q87R	X	X	Occult HBV Infection	G R C L	View
2	22617152	V21A	X	X	Occult HBV Infection	G R C L	View
3	22617152	E64K	C	C	Occult HBV Infection	G R C L	View
4	22617152	P163L	C	C	Occult HBV Infection	G R C L	View
5	22617152	R165S	C	C	Occult HBV Infection	G R C L	View
6	22617152	R167K	C	C	Occult HBV Infection	G R C L	View
7	22617152	G145R	S	S	Occult HBV Infection	G R C L	View
8	22617152	A251S	RT	P	Occult HBV Infection	G R C L	View
9	22617152	D30V	RT	P	Occult HBV Infection	G R C L	View
10	22617152	L28F	RT	P	Occult HBV Infection	G R C L	View
11	22617152	P15R	PreS	S	Occult HBV Infection	G R C L	View
12	22617152	P41H	PreS	S	Occult HBV Infection	G R C L	View
13	22617152	R499Q	P	P	Occult HBV Infection	G R C L	View
14	22617152	R841K	P	P	Occult HBV Infection	G R C L	View
15	22617152	S240G	RT	P	Occult HBV Infection	G R C L	View
16	22617152	S782P	P	P	Occult HBV Infection	G R C L	View
17	22617152	T266A	RT	P	Occult HBV Infection	G R C L	View
18	22617152	V39A	PreS	S	Occult HBV Infection	G R C L	View

Contents
Description

The table shows all curated mutation sites of HBV in each literature

Table Description Column Note

D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.

G
The study mentioned the virus genotype/subtype information.

R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.

S
The study provided sequence information or accession numbers.

L
The study provided the geographic region/country of data origin.

C
The study provided clinical baseline information.

I
The study involved information related to immune.

T
The study involved host target genes.